TCT 2009 schedule: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
===1:00 PM=== | ===1:00 PM=== | ||
''1:05 PM - 1:15 PM'' | ''1:05 PM - 1:15 PM'' | ||
*'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations | *'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations | ||
*'''Room:''' 104 | *'''Room:''' 104 | ||
''1:51 PM - 2:03 PM'' | ''1:51 PM - 2:03 PM'' | ||
*'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations | *'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations | ||
*'''Room:''' 104 | *'''Room:''' 104 | ||
| Line 41: | Line 41: | ||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM - 12:00 PM'' | ''10:00 AM - 12:00 PM'' | ||
*'''Event:''' Oral Abstracts- AMI | *'''Event:''' Oral Abstracts- AMI | ||
*'''Room:''' 125 | *'''Room:''' 125 | ||
| Line 48: | Line 48: | ||
== Wednesday September 23, 2009== | == Wednesday September 23, 2009== | ||
===12: | ===12:45 PM=== | ||
''12:45 PM - 12:50 PM'' | ''12:45 PM - 12:50 PM'' | ||
*'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule | *'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule | ||
*'''Room:''' 130 | *'''Room:''' 130 | ||
===1: | ===1:35 PM=== | ||
''1:35 PM - 1:45 PM'' | ''1:35 PM - 1:45 PM'' | ||
*'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule | *'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule | ||
*'''Room:''' 130 | *'''Room:''' 130 | ||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM - 4:45 PM'' | ''4:00 PM - 4:45 PM'' | ||
*'''Event:''' Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy | *'''Event:''' Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy | ||
*'''Room:''' Esplanade Ballroom | *'''Room:''' Esplanade Ballroom | ||
''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ||
== Thursday September 24, 2009== | == Thursday September 24, 2009== | ||
===8:45 AM=== | |||
''8:46 AM - 11:11 AM'' | |||
*'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI | |||
*'''Room:''' 135 | |||
===11:45 PM=== | |||
''11:45 AM - 11:57 AM'' | |||
*'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI | |||
*'''Room:''' 135 | |||
===12:09 PM=== | |||
''12:09 PM - 12:24 PM'' | |||
*'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI | |||
*'''Room:''' 135 | |||
===5:02 PM=== | |||
''5:02 PM - 5:14 PM'' | |||
*'''Event:''' Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS. Antiplatelet Agents, Bleeding, and Ischemia | |||
*'''Room:''' 135 | |||
''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ||
Revision as of 13:36, 7 August 2009
Here is the page we will use to coordinate the TV events at TCT 2009.
Click on Date for Detailed Schedule
Sunday September 20, 2009
Monday September 21, 2009
1:00 PM
1:05 PM - 1:15 PM
- Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
- Room: 104
1:51 PM - 2:03 PM
- Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
- Room: 104
Tuesday September 22, 2009
10:00 AM
10:00 AM - 12:00 PM
- Event: Oral Abstracts- AMI
- Room: 125
Wednesday September 23, 2009
12:45 PM
12:45 PM - 12:50 PM
- Event: Open Issues I: Adjunct Pharmacology. Schedule
- Room: 130
1:35 PM
1:35 PM - 1:45 PM
- Event: Open Issues I: Adjunct Pharmacology. Schedule
- Room: 130
4:00 PM
4:00 PM - 4:45 PM
- Event: Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy
- Room: Esplanade Ballroom
Thursday September 24, 2009
8:45 AM
8:46 AM - 11:11 AM
- Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI
- Room: 135
11:45 PM
11:45 AM - 11:57 AM
- Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
- Room: 135
12:09 PM
12:09 PM - 12:24 PM
- Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
- Room: 135
5:02 PM
5:02 PM - 5:14 PM
- Event: Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS. Antiplatelet Agents, Bleeding, and Ischemia
- Room: 135